Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., commonly referred to as Sun-Novo, is a leading player in the pharmaceutical industry, headquartered in Beijing, China. Established in 2003, the company has made significant strides in drug discovery and development, focusing on innovative solutions for various therapeutic areas, including oncology and cardiovascular diseases. With a strong presence in both domestic and international markets, Sun-Novo is renowned for its commitment to research and development, offering a diverse portfolio of core products and services. Their unique approach combines advanced technology with a deep understanding of patient needs, positioning them as a trusted partner in the pharmaceutical landscape. Notable achievements include successful collaborations and a growing pipeline of novel therapeutics, solidifying Sun-Novo's reputation as a key contributor to global health advancements.
DitchCarbon Score
How does Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s score of 20 is lower than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s reported carbon emissions
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Beijing Sun-Novo may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed their initiatives. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Beijing Sun-Novo to establish clear climate commitments and reduction targets to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
